OncoHost
Founded 2017 · 43 employees on LinkedIn · 2 known investors
OncoHost develops a blood-based diagnostic test that uses proteomic pattern recognition and AI to predict patient benefit from PD-1/PD-L1 immunotherapy inhibitors for oncology treatment planning. The platform analyzes tumor and host microenvironment factors in plasma or serum samples to generate personalized treatment recommendations.
Investors · 2
Frequently asked questions
- What does OncoHost do?
- OncoHost develops a blood-based diagnostic test that uses proteomic pattern recognition and AI to predict patient benefit from PD-1/PD-L1 immunotherapy inhibitors for oncology treatment planning. The platform analyzes tumor and host microenvironment factors in plasma or serum samples to generate personalized treatment recommendations.
- Who are OncoHost's investors?
- OncoHost's investors include ALIVE Israel HealthTech Fund, OurCrowd.